Amphastar Pharmaceuticals (AMPH)
(Real Time Quote from BATS)
$42.12 USD
+0.48 (1.15%)
Updated May 30, 2024 02:46 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | 0.81 |
EPS Last Quarter | 1.04 |
Last EPS Surprise | 35.06% |
ABR | 1.57 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 3.86 |
Next Year | 4.38 |
EPS (TTM) | 3.72 |
P/E (F1) | 10.79 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 173.29M | 200.41M | 753.36M | 857.73M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 182.97M | 215.91M | 776.36M | 874.30M |
Low Estimate | 166.70M | 185.40M | 723.90M | 848.76M |
Year ago Sales | 145.71M | 180.56M | 644.40M | 753.36M |
Year over Year Growth Est. | 18.92% | 10.99% | 16.91% | 13.85% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.81 | 0.98 | 3.86 | 4.38 |
# of Estimates | 5 | 4 | 5 | 4 |
Most Recent Consensus | 0.76 | 1.00 | 3.85 | NA |
High Estimate | 0.95 | 1.04 | 4.02 | 4.75 |
Low Estimate | 0.71 | 0.83 | 3.63 | 4.07 |
Year ago EPS | 0.65 | 1.15 | 3.32 | 3.86 |
Year over Year Growth Est. | 24.62% | -14.78% | 16.27% | 13.52% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 1 | 5 | 2 |
Up Last 60 Days | 2 | 0 | 5 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 0 | 2 |
Down Last 60 Days | 1 | 3 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.81 | 0.98 | 3.86 | 4.38 |
7 Days Ago | 0.81 | 0.98 | 3.86 | 4.38 |
30 Days Ago | 0.78 | 1.00 | 3.70 | 4.30 |
60 Days Ago | 0.80 | 1.00 | 3.71 | 4.37 |
90 Days Ago | 0.70 | 0.88 | 3.75 | 4.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.81 | 0.98 | 3.86 | 4.38 |
Zacks Consensus Estimate | 0.81 | 0.98 | 3.86 | 4.38 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.04 | 0.88 | 1.15 | 0.65 | NA |
Estimate | 0.77 | 0.87 | 0.70 | 0.57 | NA |
Difference | 0.27 | 0.01 | 0.45 | 0.08 | 0.20 |
Surprise | 35.06% | 1.15% | 64.29% | 14.04% | 28.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more